As of Oct 15
| -0.27 / -2.31%|
The 4 analysts offering 12-month price forecasts for Karuna Therapeutics Inc have a median target of 31.50, with a high estimate of 38.00 and a low estimate of 28.00. The median estimate represents a +175.35% increase from the last price of 11.44.
The current consensus among 4 polled investment analysts is to Buy stock in Karuna Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.